SmokingNCT02508597
Brief Tobacco Cessation Counselling: Mini Train-the-trainers Program
A study testing Physicians receiving smoking cessation training in people with Smoking, run by The University of Hong Kong at 1 site in China.
Trial summary
Physicians play a critical role in reducing tobacco use by advising smoking patients to quit. After receiving such advice to quit smoking, patients were more likely to report trying to quit, quitting for at least 24 hours, making more quit attempts, and having more successful quitting outcomes compared with those who… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Smoking
- What is being tested?
- Physicians receiving smoking cessation training
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteChina
- Study dates
- Aug 2014to Dec 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Internal medicine physicians from participating hospitals/clinics.
Who cannot join
- N/A
Trial locations and contacts
1 site in 1 country.
China1 site, 1 recruiting
- Recruiting
5/F William MW Mong Block, LKS Faculty of Medicine Building, 21 Sassoon Road, Pokfulam
Hong Kong, Guangdong
About this study
Official title: Brief Tobacco Cessation Counselling: Mini Train-the-trainers Program Among Physicians in Guangdong, China
Physicians play a critical role in reducing tobacco use by advising smoking patients to quit. After receiving such advice to quit smoking, patients were more likely to report trying to quit, quitting for at least 24 hours, making more quit attempts, and having more successful quitting outcomes compared with those who received no such advice. On the other hand, most physicians are not performing smoking cessation counselling, and miss the opportunities to advise patients to quit smoking. One of the common reasons is the lack of time. Physicians are busy and cannot afford even one minute to advice their patients to quit smoking. Other barriers include lack of training and experience, lack of knowledge and skills, no awareness about the benefits and effects of physicians' advice, no incentives and no support or requirement from hospital management that they have to do it.
We designed a brief smoking cessation counselling model (AWARD) which takes only 10-20 seconds. We will train the physicians to perform the AWARD cessation counselling model in clinic, and encourage them to participate in our brief smoking cessation intervention project using the randomized controlled trail (RCT) design and to train more peer physicians to perform brief smoking cessation counseling. We propose to investigate the effect of the training program on physicians' knowledge of tobacco cessation, practice of performing cessation counselling, and attitudes toward tobacco control policies.
Read the detailed description
Participating hospitals/clinics will invite 100-120 internal medicine physicians to take part in the brief smoking counselling intervention project and participate in a half-day mini TTT training program. The training will cover the following topics:
- Goal and the details of the brief smoking counselling intervention;
- Objective of the mini TTT training program;
- Tobacco epidemic and control measures in China and the world;
- Physicians' role in tobacco control;
- Health risks of smoking, secondhand smoke exposure;
- WHO FCTC (Framework Convention on Tobacco Control) and the MPOWER measures;
- Brief smoking cessation counselling (AWARD model), and counselling skill with practice;
- Placebo counselling and counselling skill with practice.
On the training day, the investigators will explain at the beginning of the workshop the purpose of the training, and the details of the brief smoking cessation intervention to all physicians who attend the training workshop. The investigators will explain that the participation is totally voluntary, and the participants will be invited to complete a paper-and-pencil survey before and right after the training workshop, perform smoking cessation counselling or placebo counselling among patients at their clinics, and complete online survey at 6- and 12-month follow-up. Agreement to participate in the training program will be considered as consent and participants are required to sign a written consent form.
At the end of the workshop, participants should be confident to perform brief smoking cessation counselling and placebo counselling for patients.
We hypothesize that the training program will increase the participants' knowledge level of smoking and secondhand smoke exposure and the important role of physicians in tobacco control, increase their skill and confidence of performing smoking cessation counselling, and generate stronger support for tobacco control policies.
- Conditions
- Smoking
- Being tested
- Physicians receiving smoking cessation training
- Keywords
- Smoking cessation intervention
- Medical subject headings
- Smoking
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Physicians receiving smoking cessation trainingOther
On the training day, the investigators will explain at the beginning of the workshop the purpose of the training, and the details of the brief smoking cessation intervention to all physicians who attend the training workshop.
| Study group | Role | What they receive |
|---|---|---|
| Physicians receiving smoking cessation training | Other | On the training day, the investigators will explain at the beginning of the workshop the purpose of the training, and the details of the brief smoking cessation intervention to all physicians who attend the training workshop. Receives: Other: Physicians receiving smoking cessation training |
What is being measured
The primary outcome is the main question the study is designed to answer.
KAP change from baseline at 6-month follow-up
Use questionnaire to measure the change of "Knowledge of smoking, secondhand smoke exposure, and the role of physicians in tobacco control", "Attitudes toward tobacco control policies" and "Practice of smoking cessation counseling" (KAP)
Measured: 6-month follow-up
KAP change from baseline at 12-month follow-up
Use questionnaire to measure the change of "Knowledge of smoking, secondhand smoke exposure, and the role of physicians in tobacco control", "Attitudes toward tobacco control policies" and "Practice of smoking cessation counseling" (KAP)
Measured: 12-month follow-up
Secondary outcomes (2)
Satisfaction of the mini TTT workshop
A questionnaire will be completed by workshop participants to measure satisfaction of mini TTT workshop after each workshop
Measured: 24 months
Number of peer physicians the participants trained
Measured: 30 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jul 2015 (estimated)
- Study startAug 2014
- Primary completionNov 2017 (estimated)
- Study completionDec 2017 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SmokingStudies of the same condition, open and under way.
- More trials run by The University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The University of Hong Kong
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Professor Lam Tai-Hing, The University of Hong Kong
- Investigators
- Tai Hing Lam, MD, Principal investigator, The University of Hong Kong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02508597
- Sponsor's protocol ID
- MiniTTT
- Status last verified
- Oct 2017
- First submitted
- 8 Jul 2015
- Last updated
- 6 Nov 2017
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 6 Nov 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Brief Tobacco Cessation Counselling: Mini Train-the-trainers Program Among Physicians in Guangdong, China
- ClinicalTrials.gov ID
- NCT02508597
- Acronym / sponsor ID
- MiniTTT
- Conditions
- Smoking
- Keywords
- Smoking cessation intervention
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- The University of Hong KongUniversity, hospital or other
- Study start
- Aug 2014
- Primary completion
- Nov 2017 (estimated)
- Study completion
- Dec 2017 (estimated)
- First posted
- 27 Jul 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Physicians play a critical role in reducing tobacco use by advising smoking patients to quit. After receiving such advice to quit smoking, patients were more likely to report trying to quit, quitting for at least 24 hours, making more quit attempts, and having more successful quitting outcomes compared with those who received no such advice. On the other hand, most physicians are not performing smoking cessation counselling, and miss the opportunities to advise patients to quit smoking. One of the common reasons is the lack of time. Physicians are busy and cannot afford even one minute to advice their patients to quit smoking. Other barriers include lack of training and experience, lack of knowledge and skills, no awareness about the benefits and effects of physicians' advice, no incentives and no support or requirement from hospital management that they have to do it.
We designed a brief smoking cessation counselling model (AWARD) which takes only 10-20 seconds. We will train the physicians to perform the AWARD cessation counselling model in clinic, and encourage them to participate in our brief smoking cessation intervention project using the randomized controlled trail (RCT) design and to train more peer physicians to perform brief smoking cessation counseling. We propose to investigate the effect of the training program on physicians' knowledge of tobacco cessation, practice of performing cessation counselling, and attitudes toward tobacco control policies.
Detailed description
Participating hospitals/clinics will invite 100-120 internal medicine physicians to take part in the brief smoking counselling intervention project and participate in a half-day mini TTT training program. The training will cover the following topics:
- Goal and the details of the brief smoking counselling intervention;
- Objective of the mini TTT training program;
- Tobacco epidemic and control measures in China and the world;
- Physicians' role in tobacco control;
- Health risks of smoking, secondhand smoke exposure;
- WHO FCTC (Framework Convention on Tobacco Control) and the MPOWER measures;
- Brief smoking cessation counselling (AWARD model), and counselling skill with practice;
- Placebo counselling and counselling skill with practice.
On the training day, the investigators will explain at the beginning of the workshop the purpose of the training, and the details of the brief smoking cessation intervention to all physicians who attend the training workshop. The investigators will explain that the participation is totally voluntary, and the participants will be invited to complete a paper-and-pencil survey before and right after the training workshop, perform smoking cessation counselling or placebo counselling among patients at their clinics, and complete online survey at 6- and 12-month follow-up. Agreement to participate in the training program will be considered as consent and participants are required to sign a written consent form.
At the end of the workshop, participants should be confident to perform brief smoking cessation counselling and placebo counselling for patients.
We hypothesize that the training program will increase the participants' knowledge level of smoking and secondhand smoke exposure and the important role of physicians in tobacco control, increase their skill and confidence of performing smoking cessation counselling, and generate stronger support for tobacco control policies.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Physicians receiving smoking cessation training | Other | Other: Physicians receiving smoking cessation trainingOn the training day, the investigators will explain at the beginning of the workshop the purpose of the training, and the details of the brief smoking cessation intervention to all physicians who attend the training workshop. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Internal medicine physicians from participating hospitals/clinics.
Key exclusion criteria (1 listed)
- N/A
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Physicians receiving smoking cessation trainingOn the training day, the investigators will explain at the beginning of the workshop the purpose of the training, and the details of the brief smoking cessation intervention to all physicians who attend the training workshop. | Other | Physicians receiving smoking cessation training |
Primary outcome
KAP change from baseline at 6-month follow-up
Time frame: 6-month follow-up
Use questionnaire to measure the change of "Knowledge of smoking, secondhand smoke exposure, and the role of physicians in tobacco control", "Attitudes toward tobacco control policies" and "Practice of smoking cessation counseling" (KAP)
KAP change from baseline at 12-month follow-up
Time frame: 12-month follow-up
Use questionnaire to measure the change of "Knowledge of smoking, secondhand smoke exposure, and the role of physicians in tobacco control", "Attitudes toward tobacco control policies" and "Practice of smoking cessation counseling" (KAP)
2 secondary outcomes
Satisfaction of the mini TTT workshop
Time frame: 24 months
Number of peer physicians the participants trained
Time frame: 30 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Nov 2017.
Related trials for Smoking
Enrolling by invitationObservational study
Using Smartwatches to Monitor Smoking in Real-life Situations
Smoking
Recruiting
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
Physician's Role, Smoking Cessation
RecruitingPhase 3
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Recruiting
Feasibility and Uptake of Low-Dose CT Lung Cancer Screening in Kuwait
Lung Cancer, Lung Neoplasms
Active, not recruitingPhase 4
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
Smoking Cessation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Tai Hing Lam, MD principal investigator
The University of Hong Kong
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Physicians receiving smoking cessation training in people with Smoking, run by The University of Hong Kong at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 6 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Tai Hing Lam, MD (+852 3917 9287, hrmrlth@hku.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
KAP change from baseline at 6-month follow-up (time frame: 6-month follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2017.